PHIO
PHIO PHARMA (PHIO)
NASDAQ
$1.12-$0.005 (-0.45%)
Price as of Jun 03, 2026 5:19 PM EDT
  • $12.9M
    Market Cap
  • -46.41%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
231,000
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
-100.00%
231,000
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-4.6M
+26.76%
-3.6M
-42.47%
-6.3M
-9.70%
-7.0M
-21.09%
Depreciation and Amortization Expense
3,000
+50.00%
2,000
-96.43%
56,000
-21.13%
71,000
-5.33%
Total Operating Expenses
9.2M
+24.81%
7.4M
-31.75%
10.8M
-5.57%
11.5M
-15.17%
Operating Profit
-9.2M
+24.81%
-7.4M
-31.75%
-10.8M
-5.57%
-11.5M
-15.17%
Interest Income
522,000
+113.93%
244,000
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
-13,000
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
522,000
+125.97%
231,000
N/A
0
N/A
0
+100.00%
Total Nonoperating Income and Expense
2,000
-99.13%
231,000
+11,650.00%
-2,000
-88.89%
-18,000
-108.04%
Income before Taxes
-9.2M
+24.81%
-7.4M
-31.75%
-10.8M
-5.71%
-11.5M
-13.60%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
0
N/A
N/A
N/A
N/A
N/A
Net Income
-8.7M
N/A
N/A
N/A
-10.8M
-5.70%
-11.5M
-13.60%
Net Income from Continuing Operations Applicable to Common
-8.7M
N/A
N/A
N/A
-10.8M
-5.70%
-11.5M
-13.60%
Basic EPS and Net Income
-1.45
-84.03%
-9.08
+74.62%
-5.20
-48.51%
-10.10
+871.15%
Diluted EPS and Net Income
-1.45
-84.03%
-9.08
+74.62%
-5.20
-48.51%
-10.10
+871.15%
Basic Weighted Average Shares
6.0M
+659.91%
787,466
-62.21%
2.1M
+83.32%
1.1M
-91.14%
Diluted Weighted Average Shares
6.0M
+659.91%
787,466
-62.21%
2.1M
+83.32%
1.1M
-91.14%
Balance Sheet
Cash and Cash Equivalents
21.0M
+290.77%
5.4M
-36.61%
8.5M
-27.93%
11.8M
-51.03%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
21.0M
+290.77%
5.4M
-36.61%
8.5M
-27.93%
11.8M
-51.03%
Total Current Assets
21.5M
+274.41%
5.7M
-38.47%
9.3M
-25.10%
12.4M
-49.67%
Accumulated Depreciation
228,000
-25.49%
306,000
-73.06%
1.1M
-3.32%
1.2M
+4.72%
Property and Plant and Equipment and Net
11,000
+450.00%
2,000
-66.67%
6,000
-96.72%
183,000
+16.56%
Total Long-Term Assets
11,000
N/A
0
-100.00%
3,000
-87.50%
24,000
-11.11%
Total Assets
21.5M
+274.47%
5.7M
-38.72%
9.4M
-26.92%
12.8M
-49.09%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
1.3M
+32.02%
1.0M
-37.88%
1.6M
-15.73%
1.9M
-36.80%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
232,149
N/A
0
N/A
0
-100.00%
35,000
-79.41%
Total Liabilities
1.3M
+32.02%
1.0M
-37.88%
1.6M
-17.22%
2.0M
-39.04%
Retained Earnings
-155.1M
+5.94%
-146.4M
+5.14%
-139.2M
+8.43%
-128.4M
+9.82%
Total Stockholders Equity
20.1M
N/A
0
-100.00%
7.7M
-28.68%
10.8M
-50.58%
Total Shares Outstanding
11.6M
+570.08%
1.7M
-53.73%
3.7M
+228.99%
1.1M
-91.58%
Cash Flow
Cash from Operating Activities
-8.0M
+12.19%
-7.1M
-33.84%
-10.7M
-11.38%
-12.1M
+2.29%
Capital Expenditures
12,000
+1,100.00%
1,000
-80.00%
5,000
-95.87%
121,000
+137.25%
Cash from Investing Activities
-12,000
-250.00%
8,000
+260.00%
-5,000
-95.87%
-121,000
+137.25%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
23.6M
+491.59%
4.0M
-46.09%
7.4M
+28,611.54%
-26,000
-100.12%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
-3,197.84%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-63.90%
N/A
N/A
N/A
-97.63%
+61.51%
-60.45%
-6.95%
Return on Equity
-86.35%
N/A
N/A
N/A
-116.61%
+66.43%
-70.06%
-7.85%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
16.03
+183.60%
5.65
-0.94%
5.71
-11.12%
6.42
-20.36%
Cash Ratio
15.69
+195.99%
5.30
+2.05%
5.20
-14.48%
6.08
-22.52%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow